These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5695801)

  • 21. [Epidemiological study of toxoplasmosis at Kinshasa and in lower Zaire].
    Dumas N; Cazaux M; Tshikom K; Mwinba K; Nsinba ; Salaun JJ; Brochier B; Seguela JP
    Ann Soc Belg Med Trop; 1990 Dec; 70(4):289-96. PubMed ID: 2291694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The significance of toxoplasma infections in eye diseases in Turkey].
    Ozcan K
    Mikrobiyol Bul; 1975 Oct; 9(4):281-90. PubMed ID: 781475
    [No Abstract]   [Full Text] [Related]  

  • 23. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007.
    Hofhuis A; van Pelt W; van Duynhoven YT; Nijhuis CD; Mollema L; van der Klis FR; Havelaar AH; Kortbeek LM
    Epidemiol Infect; 2011 Apr; 139(4):530-8. PubMed ID: 20492743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological survey of toxoplasmosis in the Transvaal.
    Mason PR; Jacobs MR; Fripp PJ
    S Afr Med J; 1974 Aug; 48(40):1707-9. PubMed ID: 4605108
    [No Abstract]   [Full Text] [Related]  

  • 25. Toxoplasmosis in Peru. Geographic prevalence of Toxoplasma gondii antibodies in Peru studied by indirect fluorescent antibody technique.
    Cantella R; Colichon A; Lopez L; Wu C; Goldfarb A; Cuadra E; Latorre C; Kanashiro R; Delgado M; Piscoya Z
    Trop Geogr Med; 1974 Jun; 26(2):204-9. PubMed ID: 4605392
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevalence of antibodies against agents causing hepatitis, malaria, syphilis and toxoplasmosis in 5 different human populations of the Brazilian Amazonia].
    Ferraroni JJ; Lacaz Cda S
    Rev Inst Med Trop Sao Paulo; 1982; 24(3):155-61. PubMed ID: 6760350
    [No Abstract]   [Full Text] [Related]  

  • 27. Serologic diagnosis of toxoplasmosis and prevalence of Toxoplasma gondii antibodies in selected feline, canine, and human populations.
    Behymer RD; Harlow DR; Behymer DE; Franti CE
    J Am Vet Med Assoc; 1973 Jun; 162(11):959-63. PubMed ID: 4574472
    [No Abstract]   [Full Text] [Related]  

  • 28. Serodiagnosis of toxoplasmosis in Bahrain.
    Tabbara KS; Saleh F
    Saudi Med J; 2005 Sep; 26(9):1383-7. PubMed ID: 16155652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of anti-Toxoplasma gondii antibodies among Orang Asli (aborigines) in Peninsular Malaysia.
    Hakim SL; Radzan T; Nazma M
    Southeast Asian J Trop Med Public Health; 1994 Sep; 25(3):485-9. PubMed ID: 7777912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Toxoplasmosis in Bamako (Republic of Mali). Incidence of the disease in women of child-bearing age].
    Maiga Y; Samaké M; Marjolet M
    Med Trop (Mars); 1984; 44(4):319-22. PubMed ID: 6521630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the microprecipitation method in agar gel (MPA) in the diagnostics of toxoplasmosis. 3. Correlation of MPA, complement-fixation reaction (CFT) and Sabin-Feldman's dye test (SFT) in serodiagnosis of human toxoplasmosis.
    Hübner J; Uhlíková M
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):70-84. PubMed ID: 4196795
    [No Abstract]   [Full Text] [Related]  

  • 32. [Distribution of anti-Toxoplasma antibodies in relation to age in the Turin area].
    Giuliani G; Paggi GC; Errico G; Varetti G; Novara O; Bolgiani MP; Morbidelli R; Sernia O
    Ann Sclavo; 1978; 20(2):206-16. PubMed ID: 742934
    [No Abstract]   [Full Text] [Related]  

  • 33. [Toxoplasmosis in patients in 14 Venezuelan states].
    Bonfante-Garrido R; de Alvarez NM; de Anzola NH; de Crespo LR; Bonfante Cabarcas R; de Peñaloza SC
    Bol Oficina Sanit Panam; 1984 Jun; 96(6):502-10. PubMed ID: 6235818
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of toxoplasma antibody titer in normal man].
    Okisaka S; Kotani H
    Ganka; 1970 Jul; 12(7):604-9. PubMed ID: 5466380
    [No Abstract]   [Full Text] [Related]  

  • 35. [Enzyme-linked-immunosorbent assay (ELISA) for demonstrating antibodies against toxoplasmosis].
    Walter GH; Manthey KF
    Klin Monbl Augenheilkd; 1983 Apr; 182(4):314-7. PubMed ID: 6345916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroepidemiology of Toxoplasma infection in a metropolitan region of Brazil.
    Fernandes GC; Azevedo RS; Amaku M; Yu AL; Massad E
    Epidemiol Infect; 2009 Dec; 137(12):1809-15. PubMed ID: 19470195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Toxoplasma gondii antibodies among children and teenagers in Italy.
    Moschen ME; Stroffolini T; Arista S; Pistoia D; Giammanco A; Azara A; De Mattia D; Chiaramonte M; Rigo G; Scarpa B
    Microbiologica; 1991 Jul; 14(3):229-34. PubMed ID: 1921744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of toxoplasma dye test antibodies in a medically indigent adult population in Dallas, Texas.
    Southern PM
    Tex Rep Biol Med; 1968; 26(3):357-62. PubMed ID: 5707894
    [No Abstract]   [Full Text] [Related]  

  • 39. Seroprevalence of toxoplasmosis in HIV infected patients in Pondicherry.
    Shivaprakash MR; Parija SC; Sujatha S
    J Commun Dis; 2001 Sep; 33(3):221-3. PubMed ID: 12206044
    [No Abstract]   [Full Text] [Related]  

  • 40. [The diagnosis of toxoplasmosis in the Lomé University Hospital Center].
    Agbo K; David M; Amavi-Tete T; Deniau M
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):659-63. PubMed ID: 1819416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.